MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway
Authors: Hua-Chao Yang
Jun-Yi Wang
Bang-Qing Wang
Yu-Shuai Gao
Sen Hu
Xing-Yao Bu
Bin Yang
Journal: Brain Research Bulletin (2018)
Discipline: NEUROSCIENCE & BEHAVIOR
Keywords: Apoptosis; Glioma; MAPK signaling pathway; MicroRNA-449a; Notch1
Affiliations: Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China., Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China; Henan University of Chinese Medicine, Zhengzhou 450046, PR China., Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China; Henan University of Chinese Medicine, Zhengzhou 450046, PR China. Electronic address: .

Abstract:  As the most common and lethal of intracranial tumors, glioma accounts for 81% of all malignant brain tumors. Research data have identified the role of microRNAs (miRs) as functional suppressors in the progression of Glioma. The present study aimed to, ascertain as to whether microRNA-499a (miR-499a) influences cell proliferation and apoptosis through the MAPK signaling pathway by targeting Notch1 in glioma. Both glioma and adjacent tissues between 2012-2016, were obtained from People's Hospital of Zhengzhou University (Henan Provincial People's Hospital). The collected glioma cells were treated with miR-449a mimic, miR-449a inhibitor, siRNA-Notch1, or SB230580 (an inhibitor of the MAPK signaling pathway). Verification of the targeting effect of miR-449a on Notch1 was provided by a dual-luciferase reporter gene assay. The expressions of miR-449a, Notch1, p38 mitogen-activated protein kinase (p38MAPK), extracellular regulated protein kinases (ERK1/2), B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (bax), CyclinD1, and phosphorylation of p38MAPK (p-p38MAPK) and ERK1/2 (p-ERK1/2) in tissues and cells were detected by means of reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blot analysis methods. Cellular processes of proliferation, cell cycle and apoptosis were evaluated by MTT and BrdU assays as well as flow cytometry, respectively. Notch1 was subsequently identified to be a target gene of miR-499a. After the cells were treated with miR-449a mimic, siRNA-Notch1 or SB230580, decreased expressions of Notch1, Bcl-2, CyclinD1, ERK1/2 and p-ERK1/2, cell proliferation as well as cells arrested at the S stage with elevated expressions levels of p38MAPK, p-p38MAPK, Bax, as well as increased cell apoptosis and number of cells arrested in G0/G1 stage were assessed. Taken together, based on the evidence obtained from the present study, assertions were subsequently made suggesting that MiR-499a targeted-inhibition of Notch1 may be a promising future therapeutic strategy for glioma treatment, by means of overexpressing of miR-499a resulting in the inhibition of glioma cell proliferation and promotion of cell apoptosis through suppression of the MAPK signaling pathway by decreasing Notch1. 

Retracted: No

PubPeer comments:
 Fig 6C.  Western blot analysis results shows that miR-449a decreases the protein levels of Notch1, Bcl-2, CyclinD1 and ERK1 2 yet elevates those of p38MAPK and Bax. ... Panel C, protein bands of Notch1, p38MAPK, ERK1 2, Bcl-2, CyclinD1, Bax, p-p38MAPK and p-ERK1 2 among the groups . ![file] The resolution is not brilliant, but enough to see the resemblance between the loading control and (for instance) Figs 5(b) of [Gao et al (2019)] and 7(b) from [Luo et al (2018)] . ![file] Figs 9A from [Wu et al (2018a)] and 5C from [Wu et al (2018)] . Many other examples in the linked threads. ![] ,